Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
The systemic capillary leak syndrome: a case series of 28 patients from a European registry.
[systemic capillary leak syndrome]
The
systemic
capillary
leak
syndrome
(
SCLS
)
is
a
rare
disease
characterized
by
life-threatening
attacks
of
capillary
hyperpermeability
.
To
describe
the
clinical
characteristics
,
laboratory
findings
,
treatments
,
and
outcomes
of
patients
with
SCLS
who
were
not
previously
reported
in
the
literature
.
Case
series
.
Patients
referred
to
a
European
multicenter
SCLS
registry
between
January
1997
and
July
2010
.
28
patients
with
SCLS
.
Frequency
,
severity
of
attacks
,
and
vital
status
were
assessed
every
6
months
,
from
diagnosis
to
the
end
of
the
study
.
13
men
and
15
women
referred
to
the
registry
who
were
not
previously
reported
in
the
literature
had
252
attacks
.
Median
age
at
disease
onset
was
49
.
1
years
(
range
,
5
.
4
to
77
.
7
years
)
,
and
median
annual
frequency
of
attacks
was
1
.
23
(
range
,
0
.
13
to
21
.
18
)
per
patient
.
Monoclonal
IgG
gammopathy
was
observed
in
25
patients
(
89
%
)
.
Preventive
treatment
included
intravenous
immunoglobulin
(
n
=
18
)
,
terbutaline
(
n
=
9
)
,
and
aminophylline
(
n
=
10
)
.
Eight
patients
died
(
29
%
)
;
1
-
year
survival
was
89
%
,
and
5
-
year
survival
was
73
%
.
Death
was
directly
related
to
SCLS
attacks
in
6
of
8
cases
(
75
%
)
.
In
10
patients
with
a
prediagnosis
period
greater
than
6
months
who
received
preventive
treatment
,
the
annual
frequency
of
attacks
after
diagnosis
decreased
by
a
median
of
1
.
55
(
range
,
0
.
14
to
8
.
84
)
per
patient
.
Five
years
after
diagnosis
,
survival
was
85
%
in
23
patients
who
had
received
prophylactic
treatment
and
20
%
in
5
patients
who
had
not
.
The
benefits
of
preventive
treatment
could
not
be
precisely
ascertained
because
of
the
small
sample
size
and
because
most
patients
received
several
treatments
.
Clinical
experience
with
these
28
patients
with
SCLS
suggests
that
prophylactic
treatment
with
β
(
2
)
-
agonists
or
intravenous
immunoglobulin
may
reduce
the
frequency
and
severity
of
attacks
and
may
improve
survival
.
Université
Pierre
et
Marie
Curie
,
Paris
,
France
.
Diseases
Validation
Diseases presenting
"systemic capillary leak syndrome"
symptom
systemic capillary leak syndrome
This symptom has already been validated